Related Experiment Videos
Cost-effectiveness of routine blood type and screen testing for cesarean section
S B Ransom1, G Fundaro, M P Dombrowski
1Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
The Journal of Reproductive Medicine
|August 12, 1999
Summary
Routine blood type and screen testing before cesarean sections is not useful for patients without risk factors. Eliminating this practice can improve patient care and reduce costs.
Area of Science:
- Obstetrics and Gynecology
- Transfusion Medicine
Background:
- Cesarean sections are common surgical procedures.
- Blood transfusions may be necessary during cesarean sections.
- Admission blood type and screen testing is a standard practice for many surgical procedures.
Purpose of the Study:
- To assess the clinical utility and economic viability of routine blood type and screen testing upon admission for patients undergoing cesarean section.
- To determine if routine testing impacts patient care or resource allocation.
Main Methods:
- A retrospective chart review was performed.
- Data was collected over a three-year period at a tertiary care hospital.
- Included patients who underwent cesarean section and received a blood transfusion.
Main Results:
- Out of 3,962 cesarean sections, 132 (3.3%) patients required transfusion.
- Most transfusions were linked to known risk factors (e.g., previous C-section, placenta previa, anemia).
- Only 0.8 per 1,000 cesarean sections involved urgent transfusion without identifiable admission risk factors.
Conclusions:
- Routine admission blood type and screen testing for cesarean section is not beneficial for patients without identified risk factors.
- Discontinuing routine testing in these cases can enhance patient care.
- In rare urgent situations without risk factors, O negative blood can be used initially.